New campaign warns that curiosity and peer pressure can turn a single experiment with drugs into a lifelong struggle ...

Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an oral pill called ...

Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.